Skip to content
Dendreon
  • News
  • Contact Us
  • About
  • Science and Services
    • Cellular Therapy Manufacturing
    • Provenge Immunotherapy
  • Publications
  • Careers
PROVENGE Activation of Immune Function Is Related to Overall Survival in Patients with Advanced Prostate Cancer
August 3, 2012

PROVENGE Activation of Immune Function Is Related to Overall Survival in Patients with Advanced Prostate Cancer

  • Topics: Clinical Study, How Provenge Works, Phase 3 Post Hoc
  • Published In: Cancer Immunology, Immunotherapy
Read the full article
LinkedInShareTweet
Dendreon
© Dendreon Pharmaceuticals LLC. All Rights Reserved. 2023.
  • Privacy Policy
  • Legal Notice
  • Site Map
  • Linkedin
  • Facebook
  • Twitter